SIRT5 and acute myeloid leukemia: SIRT5 knockdown or pharmacological inhibition with NRD167 is associated with reduced OXPHOS, reduced GSH levels, and increased mitochondrial superoxide, suggesting that AML cells depend on SIRT5 to maintain redox homeostasis (Yan et al., 2021).